Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2020, Vol. 11 Issue (1) : 1-16     DOI: 10.14336/AD.2019.0507
Orginal Article |
Neuropsychological Deficits Chronically Developed after Focal Ischemic Stroke and Beneficial Effects of Pharmacological Hypothermia in the Mouse
Weiwei Zhong1,2, Yan Yuan1,3, Xiaohuan Gu1,2, Samuel In-young Kim1, Ryan Chin1, Modupe Loye2, Thomas A Dix4, Ling Wei1, Shan Ping Yu1,2,*
1Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA 30322, USA.
2Center for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center, Decatur, GA 30033, USA.
3College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, China.
4Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC 29401, USA.
Download: PDF(1055 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

Stroke is a leading cause of human death and disability, with around 30% of stroke patients develop neuropsychological/neuropsychiatric symptoms, such as post-stroke depression (PSD). Basic and translational research on post-stroke psychological disorders is limited. In a focal ischemic stroke mouse model with selective damage to the sensorimotor cortex, sensorimotor deficits develop soon after stroke and spontaneous recovery is observed in 2-4 weeks. We identified that mice subjected to a focal ischemic insult gradually developed depression/anxiety like behaviors 4 to 8 weeks after stroke. Psychological/psychiatric disorders were revealed in multiple behavioral examinations, including the forced swim, tail suspension, sucrose preference, and open field tests. Altered neuronal plasticity such as suppressed long-term potentiation (LTP), reduced BDNF and oxytocin signaling, and disturbed dopamine synthesis/uptake were detected in the prefrontal cortex (PFC) during the chronic phase after stroke. Pharmacological hypothermia induced by the neurotensin receptor 1 (NTR1) agonist HPI-363 was applied as an acute treatment after stroke. A six-hr hypothermia treatment applied 45 min after stroke prevented depression and anxiety like behaviors examined at 6 weeks after stroke, as well as restored BDNF expression and oxytocin signaling. Additionally, hypothermia induced by physical cooling also showed an anti-depression and anti-anxiety effect. The data suggested a delayed beneficial effect of acute hypothermia treatment on chronically developed post-stroke neuropsychological disorders, associated with regulation of synaptic plasticity, neurotrophic factors, dopaminergic activity, and oxytocin signaling in the PFC.

Keywords stroke      pharmacological hypothermia      post-stroke depression (PSD)      BDNF      oxytocin     
Corresponding Authors: Shan Ping Yu   
About author:

These authors contributed equally to this work.

Just Accepted Date: 13 May 2019   Issue Date: 15 January 2020
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Weiwei Zhong
Yan Yuan
Xiaohuan Gu
Samuel In-young Kim
Ryan Chin
Modupe Loye
Thomas A Dix
Ling Wei
Shan Ping Yu
Cite this article:   
Weiwei Zhong,Yan Yuan,Xiaohuan Gu, et al. Neuropsychological Deficits Chronically Developed after Focal Ischemic Stroke and Beneficial Effects of Pharmacological Hypothermia in the Mouse[J]. Aging and disease, 2020, 11(1): 1-16.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2019.0507     OR     http://www.aginganddisease.org/EN/Y2020/V11/I1/1
Figure 1.  Defects of synaptic plasticity in the prefrontal cortex after focal ischemic stroke. (A-B) In the amygdala, stable fEPSPs were recorded for 6 min as a baseline, high frequency stimulation (HFS) induced an LTP-like response, but no significant differences were found between stroke mice and sham (sham: n = 8, stroke: n = 9). (C-D) In the PFC of sham mice, HFS initiated the LTP as displayed in the representative traces. In the comparison to sham animals, smaller LTPs were recorded in the PFC of mice at 8 weeks after stroke (C). At 50 min of the recording, the slope of fEPSP was significantly reduced in the PFC of stroke mice than sham controls (D). (E-F) Representative traces are pair-pulse response with a 40 ms interval in PFC. Stroke insult notably reduced the pair-pulse ratio of fEPSPs at 20 ms and 40 ms intervals (Sham: n = 8, Stroke: n = 9; *P < 0.05, **P < 0.01; Student’s t-test).
Figure 2.  Gene expression in the PFC of focal ischemic stroke mice. (A-C) In the ipsilateral PFC of the animals with stroke for 8 weeks, qPCR data suggested the mRNA level of NR1 and NR2A were significantly reduced (A, Sham: n = 5, Stroke: n = 5), which is consistent with the western blot results (B-C, Sham: n = 4, Stroke: n = 4). The mRNA level of GluR1 was significantly increased (A), although no significant difference was detected in the protein expression level of GluR1 (B-C) (*P < 0.05, **P < 0.01, ***P < 0.001; Student’s t-test). (D-F) In the western blot assessment, compared to the animals in the sham group, the protein expression levels of MBP, PSD95, oxytocin, oxytocin R, BDNF, DAT, and TH were significantly reduced in PFC of stroke animals. Arrows point to the bands of PSD95 and DAT; the two GAD65/67 bands were used in the quantification. (Sham: n = 4, Stroke: n = 5; *P < 0.05, **P < 0.01; Student’s t-test).
Figure 3.  Delayed development of neuropsychological behaviors and beneficial effects of pharmacological hypothermia after focal ischemic stroke. (A) The sucrose preference test was used to test anhedonic behavior in mice. In comparison to the sham, the stroke animals consumed significantly less sucrose 2-8 weeks post stroke and acute hypothermia treatment significantly increased the sucrose consumption at 4 weeks and 8 weeks post stroke. The main factor of treatment showed a significant difference (F=16.3, df =2, P < 0.001). No significant differences were found in the main factor of time (F = 2.24, df = 3, P = 0.088) or the interactions of time × treatment (F = 1.90, df = 6, P = 0.088). (B-C) The tail suspension (B) and forced swim test (C) were used to test the depression like behavior in mice. (B) In the tail suspension test, the stroke mice showed significantly increased immobile durations at 4-8 weeks after stroke and acute hypothermia treatment significantly reduced the immobility at 6 weeks and 8 weeks after stroke. Significant differences were detected in the main factor of time (F = 6.01, df = 3, P < 0.001), treatment (F = 11.24, df = 2, P < 0.001) and interaction of time × treatment (F = 4.79, df = 6, P < 0.001). (C) In the forced swim test, the stroke mice were immobile significantly longer than the sham and acute hypothermia treatment significantly reduced the immobility in stroke mice. There are significant differences in the main factor of time (F = 3.90, df = 3, P < 0.05) and treatment (F = 3.60, df = 2, P < 0.05). No significant difference was found in the interaction of time × treatment (F = 1.55, df = 6, P = 0.172) (D-E) The open field test was used to test the anxious-like behavior in mice. The walking traces of the test mice in the open field were shown as a representative (D). The animals traveled significantly less in the central region of the arena than sham at 6-7 weeks after stroke, while acute hypothermia treatment increased the ratio of traveling in the center region in these mice (E). (A-E, sham: n = 10, stroke: n = 10, stroke + hypothermia: n = 8) (* sham vs stroke; # stroke vs stroke + hypothermia; *, # P < 0.05, **, ## P < 0.01, ***, ### P < 0.001; Two-way ANOVA and One-way ANOVA with Fisher’s post hoc)
Figure 4.  Chronic consequences in the non-ischemic PFC after acute pharmacological hypothermia in focal ischemic stroke mice. (A) The time course of pharmacologically induced hypothermia with HPI363 in mice after stroke (stroke: n = 10, stroke + hypothermia: n = 8). (B-D) The western blot results showed both the expression levels of oxytocin and BDNF were significantly increased in the stroke mice with hypothermia treatment. Only the active form of BDNF band and the arrow pointed PSD95 band were used in the quantification. (sham: n = 4, stroke: n = 5, stroke + hypothermia: n = 4) (* sham vs stroke; # stroke vs stroke + hypothermia; * P < 0.05, **, ## P < 0.01, ***, ### P < 0.001; One-way ANOVA with Fisher’s post hoc)
Figure 5.  Acute hypothermia treatment altered the cytokines expression in the non-ischemic PFC. (A-D) The mRNA levels of cytokines were measured using qPCR analyses in the ipsilateral PFC at 1day, 3days and 7days after stroke. Stroke induction significantly enhanced the mRNAs of the pro-inflammatory cytokines TNF-α (A), IL-1β (B) and IL-6 (C) at 1day, 3day, and 7days post stroke. Hypothermia treatment significantly attenuated the TNF-α (A) at 1day and 3days post stroke and IL-6 at 1day and 7days post stroke. On the contrary, the mRNA of anti-inflammatory factor IL-10 (D) was significantly increased in stroke mice and hypothermia treatment reduced the IL-10 mRNA level in stroke mice at 1 day, 3 day and 7 days post-surgery. (n = 3 in each groups) (E-F) Western blot was used to quantify the cytokine levels in PFC at 3 days post stroke. Stroke induction enhanced the protein expression of TNF-α, IL-1β, and IL-10, while acute hypothermia treatment significantly reduced the TNF-α expression level in PFC at 3 days post stroke. No change was observed in the pro-inflammation cytokine IL-6 between groups. Only the active form of IL-1β was used in the quantification. (sham: n = 4, stroke: n = 4, stroke + hypothermia: n = 4) (* sham vs stroke; # stroke vs stroke + hypothermia; *, # P < 0.05, **, ## P < 0.01, ***, ### P < 0.001; One-way ANOVA with Fisher’s post hoc)
Figure 6.  Physical cooling alleviated psychological behaviors in mice after stroke. The behavioral assessments were performed at 6-7 weeks post stroke in the experimental mice. (A) In the sucrose preference test, physical cooling prevented the loss of sucrose preference to levels similar to the drug induced hypothermia group. (B) In the tail suspension test, physical cooling significantly attenuated the immobility in stroke mice. (C) No significant differences were detected between groups in the forced swim test. (D) In the open field test, although physical cooling failed to significantly increase the travel distance ratio in the center, no differences were found between sham and stroke mice with physical cooling treatment. (sham: n = 10, stroke: n = 10, stroke + hypothermia: n = 8, stroke + physical cooling: n = 8; * sham vs stroke; # stroke vs stroke + hypothermia; *, # P < 0.05, **, ## P < 0.01; One-way ANOVA with Fisher’s post hoc)
[1] Folstein MF, Maiberger R, McHugh PR (1977). Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry, 40: 1018-1020
[2] Chun HY, Whiteley WN, Dennis MS, Mead GE, Carson AJ (2018). Anxiety After Stroke: The Importance of Subtyping. Stroke, 49: 556-564
[3] Ayerbe L, Ayis S, Wolfe CD, Rudd AG (2013). Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry, 202: 14-21
[4] Kim JS (2016). Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms. J Stroke, 18: 244-255
[5] Kronenberg G, Balkaya M, Prinz V, Gertz K, Ji S, Kirste I, et al. (2012). Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression. Biol Psychiatry, 72: 273-281
[6] Boyko M, Kutz R, Gruenbaum BF, Cohen H, Kozlovsky N, Gruenbaum SE, et al. (2013). The influence of aging on poststroke depression using a rat model via middle cerebral artery occlusion. Cogn Affect Behav Neurosci, 13: 847-859
[7] Wei L, Rovainen CM, Woolsey TA (1995). Ministrokes in rat barrel cortex. Stroke, 26: 1459-1462
[8] Wang LL, Li J, Gu X, Wei L, Yu SP (2017). Delayed treatment of 6-Bromoindirubin-3'-oxime stimulates neurogenesis and functional recovery after focal ischemic stroke in mice. Int J Dev Neurosci, 57: 77-84
[9] Chen D, Wei L, Liu ZR, Yang JJ, Gu X, Wei ZZ, et al. (2018). Pyruvate Kinase M2 Increases Angiogenesis, Neurogenesis, and Functional Recovery Mediated by Upregulation of STAT3 and Focal Adhesion Kinase Activities After Ischemic Stroke in Adult Mice. Neurotherapeutics, 15: 770-784
[10] Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, et al. (2010). Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association. Stroke, 41: 2402-2448
[11] Robinson RG, Jorge RE (2016). Post-Stroke Depression: A Review. Am J Psychiatry, 173: 221-231
[12] Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J (2011). Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ, 343: d4551
[13] Lee JH, Wei L, Gu X, Wei Z, Dix TA, Yu SP (2014). Therapeutic effects of pharmacologically induced hypothermia against traumatic brain injury in mice. J Neurotrauma, 31: 1417-1430
[14] Lee JH, Wei ZZ, Cao W, Won S, Gu X, Winter M, et al. (2016). Regulation of therapeutic hypothermia on inflammatory cytokines, microglia polarization, migration and functional recovery after ischemic stroke in mice. Neurobiol Dis, 96: 248-260
[15] Lee JH, Zhang J, Yu SP (2017). Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke. Neural Regen Res, 12: 341-350
[16] Choi KE, Hall CL, Sun JM, Wei L, Mohamad O, Dix TA, et al. (2012). A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice. FASEB J, 26: 2799-2810
[17] Eagle AL, Gajewski PA, Yang M, Kechner ME, Al Masraf BS, Kennedy PJ, et al. (2015). Experience-Dependent Induction of Hippocampal DeltaFosB Controls Learning. J Neurosci, 35: 13773-13783
[18] Eagle AL, Mazei-Robison M, Robison AJ (2016). Sucrose Preference Test to Measure Stress-induced Anhedonia. Bio-protocol, 6: e1822
[19] Yankelevitch-Yahav R, Franko M, Huly A, Doron R (2015). The forced swim test as a model of depressive-like behavior. J Vis Exp
[20] Misrani A, Tabassum S, Chen X, Tan SY, Wang JC, Yang L, et al. (2018). Differential effects of citalopram on sleep-deprivation-induced depressive-like behavior and memory impairments in mice. Prog Neuropsychopharmacol Biol Psychiatry, 88: 102-111
[21] Jiang MQ, Zhao YY, Cao W, Wei ZZ, Gu X, Wei L, et al. (2017). Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice. Brain Pathol, 27: 480-498
[22] Lee JH, Zhang JY, Wei ZZ, Yu SP (2018). Impaired social behaviors and minimized oxytocin signaling of the adult mice deficient in the N-methyl-d-aspartate receptor GluN3A subunit. Exp Neurol, 305: 1-12
[23] Song M, Mohamad O, Gu X, Wei L, Yu SP (2013). Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice. Cell Transplant, 22: 2001-2015
[24] Wei L, Ying DJ, Cui L, Langsdorf J, Yu SP (2004). Necrosis, apoptosis and hybrid death in the cortex and thalamus after barrel cortex ischemia in rats. Brain Res, 1022: 54-61
[25] Calhoon GG, Tye KM (2015). Resolving the neural circuits of anxiety. Nat Neurosci, 18: 1394-1404
[26] Marsden WN (2013). Synaptic plasticity in depression: molecular, cellular and functional correlates. Prog Neuropsychopharmacol Biol Psychiatry, 43: 168-184
[27] Sweatt JD (2016). Neural plasticity and behavior - sixty years of conceptual advances. J Neurochem, 139 Suppl 2: 179-199
[28] Pittenger C (2013). Disorders of memory and plasticity in psychiatric disease. Dialogues Clin Neurosci, 15: 455-463
[29] Wang LL, Chen D, Lee J, Gu X, Alaaeddine G, Li J, et al. (2014). Mobilization of endogenous bone marrow derived endothelial progenitor cells and therapeutic potential of parathyroid hormone after ischemic stroke in mice. PLoS One, 9: e87284
[30] Kokko KP, Hadden MK, Price KL, Orwig KS, See RE, Dix TA (2005). In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier. Neuropharmacology, 48: 417-425
[31] Bissette G, Nemeroff CB, Loosen PT, Prange AJJr, Lipton MA (1976). Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature, 262: 607-609
[32] Sladojevic N, Stamatovic SM, Keep RF, Grailer JJ, Sarma JV, Ward PA, et al. (2014). Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury. Neurobiol Dis, 67: 57-70
[33] Yenari MA, Kauppinen TM, Swanson RA (2010). Microglial activation in stroke: therapeutic targets. Neurotherapeutics, 7: 378-391
[34] Gelderblom M, Leypoldt F, Lewerenz J, Birkenmayer G, Orozco D, Ludewig P, et al. (2012). The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice. J Cereb Blood Flow Metab, 32: 835-843
[35] Wei S, Sun J, Li J, Wang L, Hall CL, Dix TA, et al. (2013). Acute and delayed protective effects of pharmacologically induced hypothermia in an intracerebral hemorrhage stroke model of mice. Neuroscience, 252: 489-500
[36] Gu X, Wei ZZ, Espinera A, Lee JH, Ji X, Wei L, et al. (2015). Pharmacologically induced hypothermia attenuates traumatic brain injury in neonatal rats. Exp Neurol, 267: 135-142
[37] Lee JH, Wei L, Gu X, Won S, Wei ZZ, Dix TA, et al. (2016). Improved Therapeutic Benefits by Combining Physical Cooling With Pharmacological Hypothermia After Severe Stroke in Rats. Stroke, 47: 1907-1913
[38] Loubinoux I, Kronenberg G, Endres M, Schumann-Bard P, Freret T, Filipkowski RK, et al. (2012). Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med, 16: 1961-1969
[39] Sugerman NT, Abella BS (2009). Hospital-based use of therapeutic hypothermia after cardiac arrest in adults. J Neurotrauma, 26: 371-376
[40] Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W, et al. (2017). The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex. Neural Plast, 2017: 6871089
[41] Janak PH, Tye KM (2015). From circuits to behaviour in the amygdala. Nature, 517: 284-292
[42] Ochsner KN, Bunge SA, Gross JJ, Gabrieli JD (2002). Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J Cogn Neurosci, 14: 1215-1229
[43] Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM, Marchante AN, et al. (2011). The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav Brain Res, 223: 403-410
[44] Egorova N, Cumming T, Shirbin C, Veldsman M, Werden E, Brodtmann A (2018). Lower cognitive control network connectivity in stroke participants with depressive features. Transl Psychiatry, 7: 4
[45] Shi Y, Zeng Y, Wu L, Liu W, Liu Z, Zhang S, et al. (2017). A Study of the Brain Abnormalities of Post-Stroke Depression in Frontal Lobe Lesion. Sci Rep, 7: 13203
[46] Vahid-Ansari F, Lagace DC, Albert PR (2016). Persistent post-stroke depression in mice following unilateral medial prefrontal cortical stroke. Transl Psychiatry, 6: e863
[47] Brecht S, Waetzig V, Hidding U, Hanisch UK, Walther M, Herdegen T, et al. (2009). FK506 protects against various immune responses and secondary degeneration following cerebral ischemia. Anat Rec (Hoboken), 292: 1993-2001
[48] Nordborg C, Johansson BB (1996). Secondary thalamic lesions after ligation of the middle cerebral artery: an ultrastructural study. Acta Neuropathol, 91: 61-66
[49] Tennant KA, Taylor SL, White ER, Brown CE (2017). Optogenetic rewiring of thalamocortical circuits to restore function in the stroke injured brain. Nat Commun, 8: 15879
[50] Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O (2013). Neuroinflammation and psychiatric illness. J Neuroinflammation, 10: 43
[51] Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, et al. (2001). Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res, 105: 45-55
[52] Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. (2010). A meta-analysis of cytokines in major depression. Biol Psychiatry, 67: 446-457
[53] Eyre HA, Air T, Pradhan A, Johnston J, Lavretsky H, Stuart MJ, et al. (2016). A meta-analysis of chemokines in major depression. Prog Neuropsychopharmacol Biol Psychiatry, 68: 1-8
[54] Merendino RA, Di Rosa AE, Di Pasquale G, Minciullo PL, Mangraviti C, Costantino A, et al. (2002). Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm, 11: 265-267
[55] Owen BM, Eccleston D, Ferrier IN, Young AH (2001). Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand, 103: 226-228
[56] Gertz K, Kronenberg G, Kalin RE, Baldinger T, Werner C, Balkaya M, et al. (2012). Essential role of interleukin-6 in post-stroke angiogenesis. Brain, 135: 1964-1980
[57] Hewett SJ, Jackman NA, Claycomb RJ (2012). Interleukin-1beta in Central Nervous System Injury and Repair. Eur J Neurodegener Dis, 1: 195-211
[58] Spalletta G, Cravello L, Imperiale F, Salani F, Bossu P, Picchetto L, et al. (2013). Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J Neuropsychiatry Clin Neurosci, 25: 255-263
[59] Kronenberg G, Gertz K, Heinz A, Endres M (2014). Of mice and men: modelling post-stroke depression experimentally. Br J Pharmacol, 171: 4673-4689
[60] Yang L, Zhang Z, Sun D, Xu Z, Yuan Y, Zhang X, et al. (2011). Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. Int J Geriatr Psychiatry, 26: 495-502
[61] Zhou Z, Lu T, Xu G, Yue X, Zhu W, Ma M, et al. (2011). Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism. Clin Chem Lab Med, 49: 185-189
[62] Frijling JL (2017). Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals. Eur J Psychotraumatol, 8: 1302652
[63] Nemeroff CB, Bissette G, Manberg PJ, Osbahr AJ3rd, Breese GR, Prange AJJr (1980). Neurotensin-induced hypothermia: evidence for an interaction with dopaminergic systems and the hypothalamic--pituitary--thyroid axis. Brain Res, 195: 69-84
[64] Boules M, Li Z, Smith K, Fredrickson P, Richelson E (2013). Diverse roles of neurotensin agonists in the central nervous system. Front Endocrinol (Lausanne), 4: 36
[65] Orwig KS, Lassetter MR, Hadden MK, Dix TA (2009). Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy. J Med Chem, 52: 1803-1813
[66] Lokk J, Delbari A (2010). Management of depression in elderly stroke patients. Neuropsychiatr Dis Treat, 6: 539-549
[1] Supplementary data Download
[1] Ya-Fan Zhou, Jing Wang, Man-Fei Deng, Bin Chi, Na Wei, Jian-Guo Chen, Dan Liu, Xiaoping Yin, Youming Lu, Ling-Qiang Zhu. The Peptide-Directed Lysosomal Degradation of CDK5 Exerts Therapeutic Effects against Stroke[J]. Aging and disease, 2019, 10(5): 1140-1145.
[2] Chun-Sheng Yang, Ai Guo, Yulin Li, Kaibin Shi, Fu-Dong Shi, Minshu Li. Dl-3-n-butylphthalide Reduces Neurovascular Inflammation and Ischemic Brain Injury in Mice[J]. Aging and disease, 2019, 10(5): 964-976.
[3] Xu-Xu Deng, Shan-Shan Li, Feng-Yan Sun. Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke via Inhibition of RIPK1-Mediated RIPK3/MLKL Signaling[J]. Aging and disease, 2019, 10(4): 807-817.
[4] Rongrong Han, Zeyue Liu, Nannan Sun, Shu Liu, Lanlan Li, Yan Shen, Jianbo Xiu, Qi Xu. BDNF Alleviates Neuroinflammation in the Hippocampus of Type 1 Diabetic Mice via Blocking the Aberrant HMGB1/RAGE/NF-κB Pathway[J]. Aging and disease, 2019, 10(3): 611-625.
[5] Xianmei Li, Siyang Lin, Xiaoli Chen, Wensi Huang, Qian Li, Hongxia Zhang, Xudong Chen, Shaohua Yang, Kunlin Jin, Bei Shao. The Prognostic Value of Serum Cytokines in Patients with Acute Ischemic Stroke[J]. Aging and disease, 2019, 10(3): 544-556.
[6] Huachen Huang, Shanshan Song, Suneel Banerjee, Tong Jiang, Jinwei Zhang, Kristopher T. Kahle, Dandan Sun, Zhongling Zhang. The WNK-SPAK/OSR1 Kinases and the Cation-Chloride Cotransporters as Therapeutic Targets for Neurological Diseases[J]. Aging and disease, 2019, 10(3): 626-636.
[7] Yuanyuan Ma, Yanqun Liu, Zhijun Zhang, Guo-Yuan Yang. Significance of Complement System in Ischemic Stroke: A Comprehensive Review[J]. Aging and disease, 2019, 10(2): 429-462.
[8] Ashok K. Shetty, Raghavendra Upadhya, Leelavathi N. Madhu, Maheedhar Kodali. Novel Insights on Systemic and Brain Aging, Stroke, Amyotrophic Lateral Sclerosis, and Alzheimer’s Disease[J]. Aging and disease, 2019, 10(2): 470-482.
[9] Yang Hua,Lingyun Jia,Yingqi Xing,Pinjing Hui,Xuan Meng,Delin Yu,Xiaofang Pan,Yalan Fang,Binbin Song,Chunxia Wu,Chunmei Zhang,Xiufang Sui,Youhe Jin,Jingfen Zhang,Jianwei Li,Ling Wang,Yuming Mu,Jingxin Zhong,Yuhong Zhu,Heng Zhang,Xiaoyu Cai. Distribution Pattern of Atherosclerotic Stenosis in Chinese Patients with Stroke: A Multicenter Registry Study[J]. Aging and disease, 2019, 10(1): 62-70.
[10] Fan Liu, Jianfei Lu, Anatol Manaenko, Junjia Tang, Qin Hu. Mitochondria in Ischemic Stroke: New Insight and Implications[J]. Aging and disease, 2018, 9(5): 924-937.
[11] Zhu Shuzhen, Gao Xiaoya, Huang Kaibin, Gu Yong, Hu Yafang, Wu Yongming, Ji Zhong, Wang Qing, Pan Suyue. Glibenclamide Enhances the Therapeutic Benefits of Early Hypothermia after Severe Stroke in Rats[J]. Aging and disease, 2018, 9(4): 685-695.
[12] Yan Tao, Venkat Poornima, Chopp Michael, Zacharek Alex, Yu Peng, Ning Ruizhuo, Qiao Xiaoxi, Kelley Mark R., Chen Jieli. APX3330 Promotes Neurorestorative Effects after Stroke in Type One Diabetic Rats[J]. Aging and disease, 2018, 9(3): 453-466.
[13] Zhang Zheng, Zhang Linlei, Ding Yuchuan, Han Zhao, Ji Xunming. Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence[J]. Aging and disease, 2018, 9(3): 507-522.
[14] Liu Xiangrong, Wen Shaohong, Zhao Shunying, Yan Feng, Zhao Shangfeng, Wu Di, Ji Xunming. Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP[J]. Aging and disease, 2018, 9(3): 401-411.
[15] Deng Qi-Wen, Li Shuo, Wang Huan, Lei Leix, Zhang Han-Qing, Gu Zheng-Tian, Xing Fang-Lan, Yan Fu-Ling. The Short-term Prognostic Value of the Triglyceride-to-high-density Lipoprotein Cholesterol Ratio in Acute Ischemic Stroke[J]. Aging and disease, 2018, 9(3): 498-506.
Viewed
Full text


Abstract

Cited

  Shared   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd